Is NBLWF or MRK a better dividend investment in 2026?

NBLWF currently yields 7272.73% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: NBLWF offers higher current income.

What is the dividend yield difference between NBLWF and MRK?

NBLWF has a forward dividend yield of 7272.73% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 7269.97 percentage points.

Home › Compare › NBLWF vs MRK

NBLWF vs MRK: Dividend Comparison 2026

NBLWF yields 7272.73% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NBLWF wins by $2410274215467854.50M in total portfolio value

INVESTMENT

TIME HORIZON10 years

NBLWF

● Live price

7272.73%

Share price

$0.03

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2410274215467854.50M

Annual income

$2,346,797,265,849,367,400,000.00

Full NBLWF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — NBLWF vs MRK

📍 NBLWF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NBLWF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NBLWF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NBLWF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NBLWF

Annual income on $10K today (after 15% tax)

$618,181.82/yr

After 10yr DRIP, annual income (after tax)

$1,994,777,675,971,962,300,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, NBLWF beats the other by $1,994,777,675,971,962,300,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NBLWF + MRK for your $10,000?

NBLWF: 50%MRK: 50%

100% MRK50/50100% NBLWF

Portfolio after 10yr

$1205137107733927.25M

Annual income

$1,173,398,632,924,683,700,000.00/yr

Blended yield

97.37%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NBLWF

No analyst data

Altman Z

0.8

Piotroski

6/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NBLWF buys

MRK buys

No recent congressional trades found for NBLWF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNBLWFMRK

Forward yield	7272.73% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$2410274215467854.50M ✓	$56.8K
Annual income after 10y	$2,346,797,265,849,367,400,000.00 ✓	$9,798.13
Total dividends collected	$2406023722527511.50M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: NBLWF vs MRK ($10,000, DRIP)

Year	NBLWF Portfolio	NBLWF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$737,973	$727,272.73	$11,206	$366.19	+$726.8K → NBLWF
2	$50,949,204	$50,159,573.65	$12,650	$502.35	+$50.94M → NBLWF
3	$3,290,952,620	$3,236,436,971.21	$14,407	$694.19	+$3290.94M → NBLWF
4	$198,895,692,877	$195,374,373,573.85	$16,585	$967.82	+$198895.68M → NBLWF
5	$11,248,205,430,863	$11,035,387,039,484.82	$19,342	$1,363.89	+$11248205.41M → NBLWF
6	$595,294,853,716,390	$583,259,273,905,366.10	$22,913	$1,947.19	+$595294853.69M → NBLWF
7	$29,485,699,795,433,240	$28,848,734,301,956,704.00	$27,662	$2,823.89	+$29485699795.41M → NBLWF
8	$1,366,983,294,191,483,000	$1,335,433,595,410,369,500.00	$34,159	$4,173.35	+$1366983294191.45M → NBLWF
9	$59,324,251,979,894,050,000	$57,861,579,855,109,170,000.00	$43,337	$6,308.80	+$59324251979894.01M → NBLWF
10	$2,410,274,215,467,854,300,000	$2,346,797,265,849,367,400,000.00	$56,776	$9,798.13	+$2410274215467854.50M → NBLWF

NBLWF vs MRK: Complete Analysis 2026

NBLWF — Stock

Noble Corporation plc, together with its subsidiaries, operates as an offshore drilling contractor for the oil and gas industry worldwide. The company provides contract drilling services to the oil and gas industry through its fleet of mobile offshore drilling units. It operates 19 offshore drilling units consisting of 11 floaters and eight jackups. Noble Corporation plc was founded in 1921 and is based in Altrincham, the United Kingdom.

Full NBLWF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this NBLWF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NBLWF vs SCHD NBLWF vs JEPI NBLWF vs O NBLWF vs KO NBLWF vs MAIN NBLWF vs JNJ NBLWF vs ABBV NBLWF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.